Emergent BioSolutions (EBS) – Guidance
-
Emergent BioSolutions (EBS) Reports Q3 results; updates guidance
-
Emergent BioSolutions (EBS) Misses Q4 EPS by 35c; Offers FY23 Revenue Guidance
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EBS Stock Lookup